《全日总结》恒指跌32点 瑞声扬逾6% 堡狮龙飙五成
美股道指昨(14日)倒升377点或1.6%，港股表现反覆。恒指高开4点後，早段曾倒跌158点一度低见23,671点，其後曾倒升155点曾高见23,985点，但在24,000点遇阻力并回落，尾市再度偏软。全日跌32点或0.1%，收23,797点；国指跌12点或0.1%，收9,674点。大市全日成交总额1,043.38亿元，沪、深港通南下交易录得净流入金额分别为13.44亿及17.14亿元人民币。
友邦(01299.HK)升1.6%报68.25元，汇控(00005.HK)跌0.3%报38.1元，港交所(00388.HK)升1.1%报252.4元。内银股建行(00939.HK)、农行(01288.HK)及中行(03988.HK)各升0.2%至0.4%，中国平安(02318.HK)及国寿(02628.HK)各跌0.1%及0.9%。电讯股中移动(00941.HK)跌0.4%报56.6元，联通(00762.HK)升1.7%。
手机相关股，瑞声(02018.HK)首季少赚88%，全日股价升6.5%报42.65元。舜宇(02382.HK)升3.2%。鸿腾(06088.HK)股价午後抽升18.9%，富智康(02038.HK)升3.5%。半导体股中芯(00981.HK)升1.7%，电讯设备股京信通信(02342.HK)升3.2%。
科技股方面，阿里巴巴(09988.HK)升1.2%报196.9元，腾讯(00700.HK)倒跌1.9%报421.2元，美团点评(03690.HK)跌1.7%报119.4元。此外，美图(01357.HK)及阿里健康(00241.HK)各升3.3%及4.9%，众安在线(06060.HK)跌3.1%。软件股金山软件(03888.HK)升4.4%，金蝶(00268.HK)与腾讯云达战略合作，股价升8.7%。
内需股普遍走软，中银国际报告引述万洲(00288.HK)管理层预期，美国业务受餐饮业因疫情关门影响，万洲股价跌4.5%，为跌幅最大蓝筹。中国旺旺(00151.HK)跌2.2%。多只医药股急升，信达生物(01801.HK)治疗细胞癌新药研究达主要研究终点，股价8.7%报43.05元。华领医药(02552.HK)急升15.9%，三生制药(01530.HK)升11.7%。
敏华控股(01999.HK)截至3月底止全年纯利升20.1%，股价午後抽升19.3%报5.5元。堡狮龙(00592.HK)获非凡中国(08032.HK)入主，堡狮龙股价弹51.4%报0.224元，非凡中国升5.4%。途屹控股(01701.HK)股价急泻52.2%报1.42元。昨遭以折让价大额售股的中国飞鹤(06186.HK)，股价回升2.9%报13.64元。
新股方面，沛嘉医疗(09996.HK)收25.8元，较上市价15.36元高68%；建业新生活(09983.HK)收8.37元，较上市价6.85元高22.2%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
